UM Ventures News
![Alba Therapeutics Corporation Alba Therapeutics Corporation](https://www.umventures.org/sites/default/files/styles/medium/public/alba.jpg?itok=gvS2K8hB)
Congratulations to Alba Therapeutics for Reporting Positive Phase IIb Trial Results
Tuesday, February 11, 2014
![Douglas Ross Douglas Ross](https://www.umventures.org/sites/default/files/styles/medium/public/ross.jpg?itok=thlAz0Bz)
Commercial Success: UMB Researcher-Developed BCRP Patent Portfolio Licensed Three Times in 2013
Wednesday, February 5, 2014
![Rexahn Pharmaceuticals Rexahn Pharmaceuticals](https://www.umventures.org/sites/default/files/styles/medium/public/rexahn_logo.jpg?itok=CPnm_QUd)
Rexahn Initiates Phase Ib Clinical Trial of RX-3117 for Treatment of Solid Tumors
Thursday, January 23, 2014
![Dr. Martha J. Connolly Dr. Martha J. Connolly](https://www.umventures.org/sites/default/files/styles/medium/public/connolly.png?itok=rUOqj93f)
Bioentrepreneurship Leader Joins UM Ventures Team
Friday, January 10, 2014
![PaxVax, Rexahn, and Analytical Informatics PaxVax, Rexahn, and Analytical Informatics](https://www.umventures.org/sites/default/files/styles/medium/public/three-companies.png?itok=Ik4Iaq-7)
Three Companies with UMB Roots Make Progress in Late 2013
Thursday, December 19, 2013
![Jim Hughes featured on BioBuzz Jim Hughes featured on BioBuzz](https://www.umventures.org/sites/default/files/styles/medium/public/biobuzz.png?itok=xWPOcLoo)
Jim Hughes and UM Ventures Featured on BioBuzz
Saturday, November 30, 2013
![Thomas R. Fuerst Thomas R. Fuerst](https://www.umventures.org/sites/default/files/styles/medium/public/thomasfuerst.jpg?itok=_iZTHHfY)
New IBBR Director Envisions Premier Biotechnology Research Institute
Monday, November 25, 2013
Alba Therapeutics Names New CEO
Monday, November 4, 2013